One example is technologies based on bio-impedance – the body’s conductivity. Today, for example, when sepsis (an infection that causes a severe life-threatening immune reaction) is indicated, only 40% of patients are monitored in this way, and the proportion is even less for other indications.”Īccording to Toume, attempts were made to replace the invasive catheter with less invasive technology, but all of them use indirect measurements they do not measure the blood flow in the main artery. This is usually done only for critical patients for whom the value of this test justifies its invasiveness, although every patient in intensive care really needs the test. Hemonitor cofounder and CTO Samer Toume explains, “Today, in order to obtain an accurate estimate of the blood flow, you have to put a catheter into the main artery. Using a smart algorithm, it is able to identify the blood flow parameters by itself.”
Mindup digital health incubator manual#
There is no need for the doctor or medical technician who looks for a special angle in a manual ultrasound. Hemonitor cofounder and CEO Tom Mayblum says, “Our device is small, and is attached as a patch below the side of the neck. The company’s product uses ultrasound to directly measure blood flow in an artery. The company was founded by three partners with backgrounds in the medical device industry, who met during their medical engineering studies at Technion Israel Institute of Technology. The MindUP technology incubator, a partnership between Pitango Venture Capital, the Rambam Health Care Campus, medical device company Medtronic, IBM, and the Impact First investment fund, has accepted its first company – Hemonitor.Hemonitor measures blood flow in the main artery of patients arriving in intensive care. Hemonitor measures blood flow in the main artery of intensive care patients.
0 kommentar(er)
